Companies: 10,795·Total market cap: $144.5T
iBio, Inc.

iBio, Inc.

IBIONASDAQHealthcare● Active
$1.76
+$0.03(+1.45%)
Market Cap$27710525
P/E Ratio
52W High$3.82
52W Low$0.56

iBio, Inc.(IBIO)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · IBIO · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-062024-062023-062022-062021-06
Revenue
Revenue$0.40M$0.23M$0.00M$1.88M$2.37M
Cost of Revenue$0.00M$0.00M$0.00M$3.79M$1.46M
Gross Profit$0.40M$0.23M$0.00M($1.91M)$0.91M
Gross Margin %(computed)100.00%100.00%-101.22%38.34%
Operating Expenses
R&D Expenses$8.31M$5.18M$10.33M$9.83M$9.99M
G&A Expenses$10.69M$11.67M$19.02M$0.00M$21.70M
Total Operating Expenses$19.00M$16.86M$29.34M$27.79M$32.02M
Operating Income($18.60M)($16.63M)($29.34M)($29.70M)($31.11M)
Operating Margin %(computed)
Interest Income$0.44M$0.36M$0.13M$0.18M$0.14M
Interest Expense$0.21M$0.17M$0.00M$0.00M$2.45M
Income Before Tax($18.38M)($15.44M)($29.31M)($29.51M)($23.21M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($18.38M)($24.91M)($65.01M)($50.39M)($23.21M)
Net Margin %(computed)-978.79%
Per Share & EBITDA
EPS (Basic)$-1.75$-6.50$-106.18$-2889.06$-59.98
Wtd Avg Shares10.50M3.83M0.61M0.02M0.39M
EBITDA($17.04M)($14.02M)($27.85M)($25.72M)($28.55M)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解iBio, Inc.

关于iBio, Inc.(IBIO)损益表

iBio, Inc.(IBIO)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,IBIO实现营收$0.00B,毛利润$0.00B(毛利率100.00%),净利润($0.02B)(净利率-4594.25%)。

常见问题

IBIO · 4 问

iBio, Inc.(IBIO)2025财年营收为$0.00B,同比up77.8%。

IBIO revenueIBIO salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09